Obtenga las últimas noticias sobre las acciones de Renovaro con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de RENB

Últimas noticias sobre

Renovaro Biosciences

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Renovaro Inc

renBTC

Small Cap

Opinion

Press Releases

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge

News

Legal

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Smart Healthcare Is Taking Over. Here's Where the Money's Headed

Biotech

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

AMZN

AVAI

CCLD

CCLDO

CERT

GEHC

GOOG

GOOGL

HCTI

MDAI

MSFT

OMDA

RENB

TREN

Adicet Bio

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Annovis Bio

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Clene

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

Immix Biopharma

INmune Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Lantern Pharma

MAIA Biotechnology

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Plus Therapeutics

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Renovaro

Serina Therapeutics

Shattuck Labs

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Screenshot 2024-05-06 at 6.05.33 PM

General

NVDA

Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection

WIIM

Renovaro shares are trading higher. The company announced it will change its corporate name to Lunai Bioworks Inc.

Comments

Renovaro Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL